Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone plus cyclosporine vs prednisolone alone in early-onset Vogt-Koyanagi-Harada disease
jRCTs011180031Completed
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Trial of prednisolone and cyclosporine in Vogt-Koyanagi-Harada disease (VKH) (2 arms). Primary endpoint: recurrence of uveitis. Started Apr 2014; status: completed.
02
Drugs
prednisolonecyclosporine
03
Conditions
Vogt-Koyanagi-Harada disease (VKH)
Beyond the preview
Go deeper on jRCTs011180031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180031.